chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dept/Mgr: Transplant   Resolution of Symptoms: symptomatic Covid-19 Vaccine Yes/No: Yes       Date of last dose: 01/12/21 Notes: EE became symptomatic on 08/20/21: plugged ears ? called PCP because she thought she had an ear infection, but wasn?t offered an in-person apt (only telehealth) so she waited over the weekend to see if ear symptoms would resolve.  Reports that the next day, 8/21, EE felt ?off? + stiff neck + congestion/runny nose).  Called out sick on 08/22.  Covid swabbed on 08/23 with positive results.  EE articipated; wants antibody testing at Facility (told EE that once she is cleared from Facility she can go to Facility).  Facility orders were placed. VAERS & Agency (#52031)  to follow.   EE instructed to quarantine, notify manager and to keep Facility informed on health status/ Facility clearance for advice on RTW.
Pt felt pressure behind ears. Pt felt trouble taking deep breaths. Pt blood pressure was elevated. EMS called and patient treated. Taken to ER.
Presented to acute care with shortness of breath. He was recently diagnosed with COVID on 8/7/21 but was asymptomatic at the time. He was brought in by EMS from his assisted living facility after he was found to be more short of breath with room air hypoxemia with spo2 70%. His hypoxemia improved with oxygen supplementation but when he arrived to the ED he was found to be more hypoxemic and altered with minimal gag. Emergent intubation was performed. CXR demonstrated bilateral opacities.  He did not improve with ICU care and family chose comfort care. Discharge Condition:Expired
This case was reported by a consumer via call center representative and described the occurrence of chills in a female patient who received SHINGRIX for prophylaxis. On 23rd July 2018, the patient received the 1st dose of SHINGRIX. On 23rd July 2018, several hours after receiving SHINGRIX, the patient experienced chills, injection site pain and fever. On 24th July 2018, the patient experienced swollen glands. On an unknown date, the outcome of the chills, injection site pain and fever were recovered/resolved and the outcome of the swollen glands was not recovered/not resolved. It was unknown if the reporter considered the chills, injection site pain, swollen glands and fever to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. At 15:30, the patient received SHINGRIX on right arm. The night of the vaccination the patient presented with chills, fever and pain at injection site. The swollen gland was a little better but still swollen.
Initially mild at site-resolved within 36 hours. Eight days following administration, awoke with itching at injection site and three small bumps at the site. Itching continued and the area enlarged to about 3 cm circle of raised, red, hard disc that continued to itch despite Benadryl and cortisone creams for 3 days. The redness resolved over the corse of the next week.
Patient has developed a rash on which started on her hands but gradually  on all over her body  2 weeks after receiving the vaccine
Patient reported severe tinnitus the night following vaccinations - has persisted thus far as of 4/29/19.
This spontaneous prospective pregnancy report was received from a Registered Nurse concerning to a 22 year old female patient with no drug reactions or allergies and no pertinent medical history. On 10-AUG-2015, the patient was vaccinated with the first dose of VARIVAX (Lot No. and expiration date were not provided) subcutaneously, 0.5 ml. There was no concomitant therapy. On 23-SEP-2015, when the patient was supposed to receive her second dose of VARIVAX, she found that she was pregnant. Last menstrual period was in approximately 2015 and estimate delivery date would be in approximately 2016. No treatment was given and no lab diagnostics studies were performed. The patient sought medical attention by calling to her doctor. No product quality complaint was involved. Additional information has been requested.
Patient had COVID-19 in August 2020. Patient experienced HA, febrile, chills, sore arm
Severe headache, fatigue, very sleepy about two hours after injection.  Woke about 1:00 a.m. with severe headache.  Gave two Tylenol and cold wash cloth for forehead.  Started tossing and turning about five minutes later.  Sat up in bed, fell over and struck bedside table.  EMT said he suffered stroke around 1:30 am.  He passed away on the 5th.
Patient called and complained that on day 7 after reciving the vaccine, she experienced a tennis ball size itchy red spot at the vaccine site. She said that it is still persistent at day 8.
Left face swelling with minimal redness; initial tightness in throat which subsided soon after initiating; BP=124/70, pulse ox=96%, HR=90
Information has been received from a nurse referring to a patient of unknown age and gender. On 06-MAY-2015 the patient was vaccinated with a dose of improperly stored (Merck) VARIVAX (dose 0.5 ml, lot# and expire date not reported) subcutaneously. No adverse experiences were reported. Additional information has been requested.
Patient. Experienced 2 seizures laying 15 seconds each. Patient has no medical history or taking any medical medications.
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium
Patient received a vaccine past the 30 day storage on the refrigerator; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 immunisation.     Patient was not allergic to medicine/food. Patient had no acute/chronic illnesses.     On 13-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not receive any concomitant medication.  Patient received booster dose of Moderna vaccine.  On 25-Feb-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Patient did not experience any side effects yet.  No treatment medication was reported.
Patient fell from chair and hit head on table in waiting area approx. 5 minutes after receiving vaccine.  Resulting from syncope event.  Patient stated she has anxiety and is nervous when receiving vaccines.  She had her boyfriend in the car and he came in and waited with her for approx. 20 to 30 more minutes.  Patient had a small egg on forehead from hitting table and was given an ice bag and water to aid with symptoms.  Patient stated she was trying to "breath through it".  May have over breathed and resulted in too much CO2.  Patient had no other episodes or symptoms following  fainting.  Patient was contacted and checked on that evening and the next morning, she stated she is feeling okay.
Patient had allergic reaction - red neck, difficulty swallowing . Patient was transported to hospital. Patient was administered 0.5mg Epi, sub-Q during transport.
7 X 9 cm. area of redness and edema.  First noticed on 7-19-09.  - itching.  7/20/09 7 X 3 1/2 cm.  Redness noted ice packs, BENADRYL
patient started to feel like his throat was itchy and it was hard to swallow, gave patient 50mg of liquid benedryl and over the course of about an hour his symptoms resolved.
Entire body rash for 7 days, started at my neck and then to involve my entire body.  Fever 101.8-102.9 for 3 days with 1 gram Tylenol and Benadryl.  Weakness for a week, unable to work.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 81-year-old female patient who received Flu seasonal TIV Dresden. On an unknown date, the patient received seasonal influenza vaccine at an unknown dose. On an unknown date, an unknown time after receiving Seasonal Influenza vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to Seasonal Influenza vaccine. Additional details were provided as follows: the age at vaccination was not reported. the patient received the flu vaccine several times in past and did not have any other adverse event other than soreness in arm. This case has been linked with case US2016143211 as reported by same reporter.
No additional adverse effects reported.; On 01-JUN-2020 a patient was administered an improperly stored dose of M-M-R II.; This spontaneous report was received from an administrator, referring to a patient of unknown gender and age. The patient's concurrent conditions, pertinent medical history, previous drug reactions or allergies, and concomitant therapies were not provided.  On 01-JUN-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (dosage schedule, vaccination scheme, route of administration, and anatomical site of vaccination were not reported; lot number S014430 has been verified to be a valid lot number, expiration date reported and validated as 09-MAY-2021) as prophylaxis (product storage error).  According to the reporter, the administered dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) experienced a temperature excursion during a timeframe of 20 hours. Furthermore, it was reported that, the temperature to evaluate the storage vaccine was unknown by reporter. No previous temperature excursion was reported. Additionally, a data logger was not involved. No adverse effects were reported.
Pt called on call Dr 11/30/12 and 12/1/12 c/o hives she believes from flu shot 11/30/12. Rx BENADRYL & CLARITIN on 12/1/12 3rd call sx worse. Sent to ED. Pt was put on Prednisone. 12-5-12 Sx persisted. Appt. Dx urticaria Rx Prednisone 40 mg daily. Seen by FNP.
pt reported dizziness, mild diaphoresis, pt reported not doing well with shots, needed to elevate feet, drank juice, ate snack
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
During a review of the LOCAL Health Dept. internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
8/5/02 Rec'd varicella vaccine 8/9/02. Returned to clinic with left arm red and swollen. Dr Rx Rocephin IM, Augmentin PO, Motrin and Benadryl. 8/12/02 returned to clinic doing better. No more varicella vaccine. Allegic to varicella Dr stated.
within 5 minutes became lightheaded, flushed, tachycardia , itching in both hands  Given Benadryl    25 mg , Pepcid , solu-medrol
Not an adverse event. Vaccine error report: Patient insisted to get Moderna booster 11/24/2021 because he received Moderna first and second dose. Per research, this was an error. However, we had a letter from his immunologist ordering the COVID-19 vaccine under immunization guidelines due to common variable immunodeficiency despite the patient's age of 16 at the time. To my recollection, neither vaccine is specifically authorized for under 18.  Patient administered Moderna 3/24/2021 and 4/22/2021 under the written order from the immunologist. Patient did not report any adverse reaction.
Case number PHEH2013US024964, is a spontaneous report from a physician received on 25 Nov 2013 and a follow up received from a physician on 07 Jan 2014. This report refers to a 71-year-old male patient. Past medical history included allergies to PERCOCET, hypertension, hypercholesterolemia, coronary artery disease, current use of long term anticoagulation, clotting disorder, arthritis, unspecified heart disease, stroke, appendectomy, tonsillectomy and cardiac catheterization. He was a former smoker and he quitted smoking in 2001. He was a non-alcoholic and not a drug abuser. His family history included heart disease to his father and mother. Concomitant medications included LIPITOR, warfarin, aspirin, COUMADIN and metoprolol succinate. He was vaccinated with FLUVIRIN (batch number: 1309801, expiry date: May 2014) inadvertently one dose from opened and unopened MDVs which were stored below the recommended mentioned temperature, at dose of 0.5 ml intramuscularly into the left deltoid on 18 Nov 2013 at 16:37. The reporter stated that, the vaccine was not frozen upon administration and was unsure if the vaccine had frozen during the temperature excursions. It was reported that, FLUVIRIN was opened and unopened MDVs reached 32 Fahrenheit (F) for 6 hours on 14 Nov 2013. On 17 Nov 2013, it reached for 31 F for 6 hours. It was further reported that he was vaccinated with one dose of FLUZONE (other manufacturer, batch number: unknown) on 18 Nov 2013. No adverse reaction was reported due to the medication errors. Follow-up received from physician on 07 Jan 2014: Updated medical history, family history, patient demographics, vitals before vaccination, concomitant medications, co-suspect vaccination with FLUZONE, site of FLUVIRIN administration and event.
Within 4 hours, I was feeling nauseas. I was feeling feverish. My arm started aching and felt really bruised into my shoulder. It was pretty stiff. This lasted for about 5 days. I was feeling feverish and flu-ish. The highest that my temperature got was 101.2. I took ibuprofen and tried to stay hydrated. I also slept to get it to go away. My arm started feeling slightly better. I wasn't able to lift it very high. I had a lot of numbness with pins and needles. I was having pains in my elbow, my shoulder, and into my neck. It was pretty rough. I went to work, but I wasn't able to do a lot of cleaning and scrubbing. About 3 weeks later, I was able to treat my shoulder mostly normal. It did go numb at one point on my left side. Last week at work, my right arm started going number up to my jaw. I felt like I was going to pass out. We had just increased my Gabapentin dosage up so we thought it might have been that. I've been babying it and doing some exercises. It still feels pretty stiff a lot. I woke up with a stiff arm again this morning. It has been kind of an ongoing thing since. When my jaw started going numb I decided I needed to figure out what was going on. I hadn't had these kind of issues with numbing before. My whole body just felt like it was drooping and I've never experienced that before.
Pfizer / BioNTech 24Feb2022/ COVID-19 Treatment 24Jul2022; Pfizer / BioNTech 24Feb2022/ COVID-19 Treatment 24Jul2022; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Feb2022 as dose 4 (booster), single (Lot number: FK9896) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HBP" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 24Jul2022, outcome "not recovered" and all described as "Pfizer / BioNTech 24Feb2022/ COVID-19 Treatment 24Jul2022". The patient received treatment from 24Jul2022 to 29Jul2022. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Jul2022) Positive; (31Jul2022) Negative; (04Aug2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.
I am a 46 yo MD who received the Moderna vaccine lot#037K20A exp 6/22/2021 on 12/24/20.  I had also just recovered from a COVID infection 5 weeks earlier.  18 hours after receiving the shot, I developed severe chills/fever/tachycardia and muscle aches and headache that lasted about 7 hours.  I slowly recovered and was better at about 36 hours post vaccine.
Wheals, papular, itching. Starting from face to chest. About 15 minutes after vaccination.
Fully vaccinated patient admit to hospital with COVID positive test.  Patient admitted for ground level fall through ED (got tangled in his garden house) with femur fracture.  Positive PCR test on 06/28/21 for COVID.  No s/s of COVID.  Had surgery and went home with no COVID complications or s/s of COVID.
The pt developed tachycardia, generalized weakness and dizziness. The pt had pain in shoulders and back. The pt experienced peeling as well. The pt had to be dismissed from school, and slept for hours at home. The pt was taken to the doctor. No fever was noted and the MD couldn't state that the symptoms were due to vaccine or not.
She got her last dose on Oct2021 but had a severe allergic reaction; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (RA). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), in Oct2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Unknown Manufacturer), for COVID-19 IMMUNIZATION. The following information was reported: HYPERSENSITIVITY (medically significant), outcome "unknown", described as "She got her last dose on Oct2021 but had a severe allergic reaction".  Additional information: it was reported that the patient completed the primary series since she has 2 doses now. Caller says she got her last dose in Oct2021 but had a severe allergic reaction. Patient is around 40 years old above.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
They thought it was the heart at first, but they think it's a thinning vessel. It can create all kinds of stuff and cause issues and problems; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 01), for COVID-19 Immunization, reaction(s): "They thought it was the heart at first, but they think it's a thinning vessel. It can create all kinds of stuff and cause issues and problems"; Bnt162b2 (Dose: 02), for COVID-19 Immunization, reaction(s): "They thought it was the heart at first, but they think it's a thinning vessel. It can create all kinds of stuff and cause issues and problems". The following information was reported: CARDIOVASCULAR DISORDER (non-serious), outcome "not recovered", described as "They thought it was the heart at first, but they think it's a thinning vessel. It can create all kinds of stuff and cause issues and problems". The events "they thought it was the heart at first, but they think it's a thinning vessel. it can create all kinds of stuff and cause issues and problems" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had the first and second vaccine and first booster, she had concerns that have gotten worse after she got the first vaccine. The doctor sent her "to all kinds of places to be checked out." "They had found stuff that patient had researched online that other people have had as well. They got issues after getting the vaccine that they never had before. They have found something that is totally similar to everyone else's issue when they took the vaccine. They though it was the heart at first, but they thought it was a thinning vessel. It could create all kinds of stuff and cause issues and problems.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201307946 same patient/drug/AE,differnt doses;
Labored deep breathing. Kinda hurts to take deep breaths. It causes me to cough a little too. Not sure if it?s a lung problem or a muscle ache problem.
This spontaneous report was received from a physician and from a support services director and refers to a patient of unknown age and gender. No information regarding the patient's medical history and concurrent conditions was provided. On 05-SEP-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection (lot # J011042, expiry date: 04-MAR-2015; exact dose and route of administration were not reported). There were no concomitant therapies reported. On an unknown date, the dose of the vaccine was exposed to the temperature excursion lasting 2928 hours with the lowest recorded temperature of 20 degrees Fahrenheit (-6.66 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.